We are coming to the end of this year and through this post we want to reflect on the impact of OLIGOFASTX in the field of RNA in Spain. Beyond the individual responsibilities of each partner, we have worked in coordination with the aim of creating an industrial fabric at national level and to make […]
Author Archives: oligofastx
Therapeutic oligonucleotides represent a breakthrough technology in genetic medicine, specifically addressing diseases at the molecular level. In this third instalment of our #DiscoveringOligonucleotides series, we dive into the development process, from target finding to custom oligonucleotide design. Search and selection of new targets: innovative strategies In the search for more effective treatments, systems biology stands […]
In the field of medicine, orphan drugs have stood out as silent heroes, bringing hope to those facing rare and neglected diseases. The term “orphan drugs” was first coined in the 1980s in the United States. The designation is given to drugs intended for the treatment of rare diseases, defined as those affecting 1 in […]
In this second issue of #DiscoveringOligonucleotides, from the OLIGOFASTX consortium we want to introduce you to RNA therapeutics. In the field of medicine, RNA therapies stand as pioneers, offering new approaches and promising advances in the treatment of diseases hitherto thought unattainable. RNA therapies operate at the most fundamental level of genetic information, using different […]
Science Week is a unique opportunity to get closer to the fascinating world of science. During this week there are various activities and events where you can learn first-hand about the latest advances and discoveries in different areas of science. Don’t miss the opportunity to take part in Science Week and broaden your knowledge! Science […]
At the intersection of technological innovation and healthcare, artificial intelligence (AI) is emerging as a transformative tool in the pharmaceutical industry. This pairing promises to accelerate the discovery of new medicines, optimise production processes and improve patient care. However, with the promise comes a number of challenges and ethical conflicts that must be carefully addressed […]
Therapeutic oligonucleotides have emerged as an exciting and promising class of drugs capable of offering treatments for genetic and/or rare diseases. These DNA or RNA fragments have revolutionised the field of modern medicine… In this blog, we will explore what therapeutic oligonucleotides are, how they work and their potential applications, with a special focus on […]
Small interfering RNA molecules (commonly known by the acronym siRNA small interfering RNA) represent one of the most revolutionary innovations in molecular biology and precision medicine. Their discovery, by scientists Andrew Fire and Craig Mello, was a milestone in biological research and was awarded the Nobel Prize in Physiology or Medicine in 2006. History of […]
From the 1980s and 1990s to the present day, the field of drug delivery has undergone an extraordinary transformation that has redefined the way we administer medical treatments. This time period has seen revolutionary advances in drug delivery, driven by the convergence of nanotechnology, gene therapy and the search for more precise and effective treatments. […]
Advances in science and technology are often the result of the dedication, passion and collaboration of brilliant minds. One such remarkable breakthrough in the field of biotechnology is the discovery of aptamers, a class of molecules that has revolutionized research and diagnostics in biology and medicine. Larry Gold and Craig Tuerk are two names that […]
Español







